Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Ed’s stories explore prescription drug ...
Uganda and Kenya are among nine African countries to have received initial doses of the HIV drug Nairobi, Kenya | AGENCIES | Demand for a twice-yearly HIV prevention injection is outpacing supply in ...
Independent Newspaper Nigeria on MSN
Nigeria pushes towards zero HIV transmission goal, holds nationwide training on lenacapavir rollout
LAGOS Nigerians living with HIV who achieve virological suppression can expect to live for 33 years without transmitting the virus, according to health experts, as nationwide training begins for the ...
South African Health Minister Aaron Motsoaledi announced that the country will launch its rollout of the twice-yearly HIV ...
Delivering his budget vote in Parliament on Wednesday, Motsoaledi said stocks will be delivered to 360 health facilities in high-burden districts.
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
Please provide your email address to receive an email when new articles are posted on . Twice-yearly lenacapavir injections reduced HIV infections by 96% in a phase 3 trial. Gilead Sciences will begin ...
A newly approved drug gives almost total protection against getting HIV. The FDA approved lenacapavir last week. Patients need just two injections of it a year to get that protection, but as NPR's ...
A Prescription Drug User Fee Act target date of August 27, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) ...
Researchers at the Manchester Institute of Biotechnology (MIB) have used engineering biology—an emerging technology that uses nature's own processes to manufacture everyday chemicals and materials—to ...
The Department of Health in South Africa is set to roll out injectable PrEP, a bi-annual HIV prevention medication, in KwaZulu-Natal. This initiative aims to provide communities with a new option for ...
South Africa has received its first batch of the highly anticipated HIV prevention medicine Lenacapavir, marking a milestone in the country’s fight against HIV. The initial shipment consists of 37,920 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results